Anavex Life Sciences Doses First Patient in Extension Study to US Phase 2 Clinical Trial of ANAVEX2-73 Biotech Investing
Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® Pharmaceutical Investing
BrainsWay Announces Shipment of 100th Deep Transcranial Magnetic Stimulation Helmet Medical Device Investing
Life Science Big News Roundup: Avricore Health Announces New Appointments; Cardiol Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation; PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program Life Science Investing
Ocular Therapeutix™ Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® Biotech Investing
